Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New drug aims to boost liver regrowth after cancer surgery

NCT ID NCT06638502

First seen Mar 12, 2026 · Last updated May 20, 2026 · Updated 12 times

Summary

This study tests a drug called HRX215 in 80 adults who had part of their liver removed due to colon cancer that spread there. The goal is to see if the drug is safe and helps the liver grow back faster. Half of the participants will get the drug, and half will get a placebo (a dummy pill). The study is in early phases (1 and 2), so it mainly checks safety and how the body handles the drug.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIVER RESECTION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Mayo Clinic

    RECRUITING

    Rochester, Minnesota, 55905, United States

    Contact

  • Rabin Medical Center

    NOT_YET_RECRUITING

    Petah Tikva, Israel

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Sheba Medical Center

    RECRUITING

    Ramat Gan, Israel

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Tel-Aviv Sourasky MC

    NOT_YET_RECRUITING

    Tel Aviv, Israel

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.